Last reviewed · How we verify

NCT02898636

Identification of Biomarkers in the Legal Medical Skin Wounds

Status unknown Last updated 9 August 2019
What this trial tests

trial testing autopsy in Legal Medical Skin Wounds in 50 participants. Status unknown.

Timeline
1 September 2016
Primary endpoint
1 December 2019
1 March 2020

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date1 September 2016
Primary completion1 December 2019
Estimated completion1 March 2020
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

Adults 18 to 100, any sex, with Legal Medical Skin Wounds. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Identify the cytokine or combination of cytokines, with the best diagnostic performance to characterize the vital nature of a skin wound in the body.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of autopsy

Trials testing the same drug.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02898636.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing